Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Janardanan Subramonia Kumar"'
Publikováno v:
Egyptian Liver Journal, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Background and objective Non-alcoholic fatty liver disease (NAFLD) is primarily perceived as a condition prevalent among obese individuals. Its pathogenesis is closely intertwined with metabolic syndrome components. However, the association
Externí odkaz:
https://doaj.org/article/8119af3f8c0c4f5a89d6acdb8704449d
Autor:
Janardanan Subramonia Kumar, Ravula Sahithya Ravali, Thangavel Mahalingam Vijayakumar, Karunanidhi Santhana Lakshmi
Publikováno v:
Obesity Medicine. 26:100359
Background Ranolazine is an oral antianginal drug that has been proven effective in reducing HbA1c and fasting plasma glucose levels in patients with type 2 diabetes in numerous studies. The current investigation was intended to study the effect of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8de99288443869f76ff0e1a269c89140
https://doi.org/10.1016/j.obmed.2021.100359
https://doi.org/10.1016/j.obmed.2021.100359
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.